Compounds and methods are provided for modulating in vitro and in vivo
processes mediated by selectin binding. More specifically, selectin
modulators and their use are described, wherein the selectin modulators
that modulate (e.g., inhibit or enhance) a selectin-mediated function
comprise a particular glycomimetic linked to a particular BASA (Benzyl
Amino Sulfonic Acid).